Thamer A. Almangour

790 total citations
63 papers, 520 citations indexed

About

Thamer A. Almangour is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Thamer A. Almangour has authored 63 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Epidemiology and 15 papers in Molecular Medicine. Recurrent topics in Thamer A. Almangour's work include Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Thamer A. Almangour is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Thamer A. Almangour collaborates with scholars based in Saudi Arabia, United States and South Korea. Thamer A. Almangour's co-authors include Abdullah A. Alhifany, Keith S. Kaye, Mohammed Alessa, Abdullah Alhammad, Khalid Eljaaly, Leen Ghonem, Hadeel Alkofide, Abdulaziz Alhossan, Mushira A. Enani and Fadilah Sfouq Aleanizy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and International Journal of Environmental Research and Public Health.

In The Last Decade

Thamer A. Almangour

53 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thamer A. Almangour Saudi Arabia 13 168 163 124 123 113 63 520
Rania M. El-Lababidi United States 10 142 0.8× 172 1.1× 97 0.8× 109 0.9× 95 0.8× 26 563
Jung-Jr Ye Taiwan 15 206 1.2× 155 1.0× 170 1.4× 92 0.7× 106 0.9× 28 495
Erin K McCreary United States 11 133 0.8× 248 1.5× 162 1.3× 130 1.1× 97 0.9× 49 533
Ryan W. Stevens United States 11 62 0.4× 155 1.0× 136 1.1× 117 1.0× 113 1.0× 63 457
Oryan Henig Israel 14 236 1.4× 288 1.8× 183 1.5× 118 1.0× 111 1.0× 39 805
Jennifer Grant Canada 13 140 0.8× 172 1.1× 93 0.8× 47 0.4× 64 0.6× 39 470
Senia Rosales-Klintz Sweden 14 140 0.8× 219 1.3× 206 1.7× 45 0.4× 205 1.8× 26 595
Endang Sri Lestari Indonesia 15 175 1.0× 206 1.3× 128 1.0× 63 0.5× 208 1.8× 90 733
Sachin Silva United States 10 155 0.9× 125 0.8× 122 1.0× 41 0.3× 191 1.7× 13 674
Rujipas Sirijatuphat Thailand 10 266 1.6× 260 1.6× 187 1.5× 177 1.4× 118 1.0× 34 651

Countries citing papers authored by Thamer A. Almangour

Since Specialization
Citations

This map shows the geographic impact of Thamer A. Almangour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thamer A. Almangour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thamer A. Almangour more than expected).

Fields of papers citing papers by Thamer A. Almangour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thamer A. Almangour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thamer A. Almangour. The network helps show where Thamer A. Almangour may publish in the future.

Co-authorship network of co-authors of Thamer A. Almangour

This figure shows the co-authorship network connecting the top 25 collaborators of Thamer A. Almangour. A scholar is included among the top collaborators of Thamer A. Almangour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thamer A. Almangour. Thamer A. Almangour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Almangour, Thamer A., et al.. (2024). Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: A multicentre cohort study. Journal of Global Antimicrobial Resistance. 38. 42–48. 5 indexed citations
4.
Aljawadi, Mohammad H., et al.. (2024). Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study. Open Forum Infectious Diseases. 11(3). ofae059–ofae059. 9 indexed citations
5.
Almangour, Thamer A., et al.. (2024). Epidemiologic and clinical updates on viral infections in Saudi Arabia. Saudi Pharmaceutical Journal. 32(7). 102126–102126. 1 indexed citations
7.
Almangour, Thamer A., Majed S. Nassar, Ziad A. Memish, et al.. (2024). Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia. Infectious Diseases and Therapy. 13(4). 667–684. 5 indexed citations
8.
Almangour, Thamer A., et al.. (2023). Heart transplantation and human immunodeficiency virus–navigating drug-drug interactions: a case report. AIDS Research and Therapy. 20(1). 55–55.
10.
Alessa, Mohammed, et al.. (2023). Adherence to evidence-based guidelines for the management of pneumonia in a tertiary teaching hospital in Riyadh. Saudi Pharmaceutical Journal. 31(8). 101678–101678. 2 indexed citations
11.
Almangour, Thamer A., et al.. (2023). Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrobial Agents and Chemotherapy. 67(8). e0040523–e0040523. 23 indexed citations
12.
Reshi, Aijaz Ahmad, Furqan Rustam, Wajdi Aljedaani, et al.. (2022). COVID-19 Vaccination-Related Sentiments Analysis: A Case Study Using Worldwide Twitter Dataset. Healthcare. 10(3). 411–411. 36 indexed citations
15.
Almangour, Thamer A., Abdullah A. Alhifany, Khalid Eljaaly, et al.. (2021). Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study. International Journal of Infectious Diseases. 108. 406–412. 15 indexed citations
16.
Eljaaly, Khalid, et al.. (2021). Efficacy of Empiric Antibiotic Coverage in Community-Acquired Pneumonia Associated with Each Atypical Bacteria: A Meta-Analysis. Journal of Clinical Medicine. 10(19). 4321–4321. 6 indexed citations
17.
Alkofide, Hadeel, et al.. (2020). Multidrug-Resistant and Extensively Drug-Resistant Enterobacteriaceae: Prevalence, Treatments, and Outcomes – A Retrospective Cohort Study. Infection and Drug Resistance. Volume 13. 4653–4662. 59 indexed citations
18.
Bustami, Rami, et al.. (2020). Knowledge regarding Zika Virus Infection among Healthcare Providers in an Academic Tertiary Care Center in Riyadh, Saudi Arabia: A Cross-Sectional Survey Study. Canadian Journal of Infectious Diseases and Medical Microbiology. 2020. 1–6. 3 indexed citations
19.
Aleanizy, Fadilah Sfouq, et al.. (2020). Evaluating the effect of antibiotics sub-inhibitory dose on Pseudomonas aeruginosaquorum sensing dependent virulence and its phenotypes. Saudi Journal of Biological Sciences. 28(1). 550–559. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026